Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

Description

The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will ingest fixed diets containing low amounts of oxalate for 5 days ingest a soluble form of glycolate and vitamin C collect urine, blood, stool during the dietary and oral dosing portions of the study and also collect breath sample during the oral glycolate test

Conditions

Kidney Stones, Kidney Calculi, Urolithiasis, Urolithiasis, Calcium Oxalate, Nephrolithiasis, Nephrolithiasis, Calcium Oxalate, Oxalate Urolithiasis, Healthy, Healthy Volunteer

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will ingest fixed diets containing low amounts of oxalate for 5 days ingest a soluble form of glycolate and vitamin C collect urine, blood, stool during the dietary and oral dosing portions of the study and also collect breath sample during the oral glycolate test

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Formers

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

Condition
Kidney Stones
Intervention / Treatment

-

Contacts and Locations

Birmingham

United States, Alabama University of Alabama at Birmingham, Birmingham, Alabama, United States, 35294

Dallas

University of Texas South Western Medical Center, Dallas, Texas, United States, 75390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * age 18-80 yrs
  • * Body Mass Index \> 18.5 kg/m2
  • * Normal fasting serum electrolytes on comprehensive metabolic profile
  • * Willing to ingest fixed diets
  • * Willing to stop supplements (vitamins including vitamin C, calcium (citrate or carbonate) and other minerals, herbal supplements, nutritional aids, probiotics) for 2 weeks before start and during study.
  • * For stone formers: first time or recurrent Calcium Oxalate stone former. Composition of most recent stone ≥ 50% calcium oxalate if available, uric acid component \<20%
  • * Chronic Kidney Disease stage 4-5
  • * Primary hyperoxaluria, Enteric (secondary) hyperoxaluria
  • * Liver, bowel, endocrine or renal diseases (other than idiopathic Calcium Oxalate kidney stones) or any other condition that may influence the absorption, transport or urinary excretion of ions, which will compromise the interpretation of results, including: Cystic fibrosis, Celiac disease, Cystinuria, Uric acid stone former, Nephrotic syndrome, Sarcoidosis, Renal tubular acidosis, Primary hyperparathyroidism, Neurogenic bladder, Urinary diversion, Chronic diarrhea, Bariatric surgery, Inflammatory bowel disease
  • * Pregnancy or breast-feeding
  • * Incompatible dietary requirements with the study, food allergies or intolerance to any of the foods in study menus
  • * Active malignancy or treatment for malignancy within 12 months prior to screening
  • * Utilization of immunosuppressive medication
  • * Uncontrolled hypertension or diabetes
  • * Diabetes type 1

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Alabama at Birmingham,

Sonia Fargue, PhD, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

2031-12-31